Richard van den Broek - Apr 8, 2025 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role
Director
Signature
/s/ Leiv Lea, as Attorney-in-Fact for Richard van den Broek
Stock symbol
CRVS
Transactions as of
Apr 8, 2025
Transactions value $
$0
Form type
4
Date filed
4/9/2025, 05:26 PM
Previous filing
Jun 24, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRVS Stock Option (Right to Buy) Award $0 +30K $0.00 30K Apr 8, 2025 Common Stock 30K $2.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to one-third (1/3rd) of the shares subject to the option on each annual anniversary measured from April 8, 2025, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.